Background: Cough variant asthma (CVA) is one of the most common respiratory diseases in children, which has a serious impact on the quality of life and daily activities of children. For severe CVA, immunomodulatory drugs are needed.
Aim: To evaluate the efficacy of salmeterol combined with budesonide in the treatment of pediatric CVA.